New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For CI;WCG;HNT;MOH;UNH;CVH;WLP;AGP;CNC;HS;HUM;AET;MDT;BSX;STJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>
June 24, 2015
06:35 EDTHUMHumana initiated with a Sector Perform at RBC Capital
Target $221.
05:59 EDTHUMHumana implied volatility of 54 at upper end of index
Subscribe for More Information
05:42 EDTUNHCatamaran downgraded to Neutral from Buy at UBS
UBS downgraded Catamaran (CTRX) to Neutral saying the stock new fully reflects the UnitedHealth (UNH) takeover deal terms. UnitedHealth management in recent meetings expressed confidence that its pending $61.50 per share purchase of Catamaran will still close in the second half of 2015, UBS tells investors.
June 23, 2015
17:03 EDTMDTMedtronic implements voluntary recall for certain lots of Covidien Shiley tubes
Medtronic announced that on May 8, it began notifying hospitals and distributors worldwide that affected lots of its Covidien Shiley tracheostomy tubes were formed with a wider-angle bend than standard models manufactured after November 29, 2012. The company initiated the field action following a small number of customer complaints that included reports of 12 serious patient injuries, such as breathing difficulties that impacted oxygen levels immediately upon tube placement or discomfort. Replacement of the tracheostomy tube with product manufactured prior to November 29, 2012 addressed the patient breathing difficulty or discomfort. The notification requested all customers and distributors to quarantine and discontinue use of all potentially affected units and return the affected product to the company as soon as possible for credit. Medtronic also took the necessary steps to prevent future shipments of the recalled products. The company also notified regulatory agencies around the world, as appropriate. Since November 29, 2012, Shiley tracheostomy tubes were shipped into Australia, Belgium, Canada, Chile, Germany, Israel, Italy, Japan, Saudi Arabia, Singapore, South Africa, Turkey, Uruguay and the United States of America.
12:35 EDTBSXBoston Scientific CEO says M&A an important strategy
Boston Scientific CEO is speaking in a CNBC interview.
11:20 EDTMDTMedtronic competitive with Edwards after approval, says Wells Fargo
Subscribe for More Information
09:50 EDTHUM, CIAnthem CFO meeting with Cigna shareholders, CNBC reports
Subscribe for More Information
09:45 EDTCI, HUMAnthem concerned Cigna may bid for Humana, CNBC's Faber reports
Subscribe for More Information
09:44 EDTCIAnthem to talk with Cigna shareholders, CNBC's Faber reports
09:22 EDTMDTMedtronic announces FDA approval for new TAVR system
Subscribe for More Information
07:44 EDTAET, HUMHumana takeover looks unlikely below $210/share, says Leerink
Subscribe for More Information
07:40 EDTCICigna price target raised to $175 from $160 at Leerink
Subscribe for More Information
07:30 EDTCIExperts: Antitrust issues exist in Cigna/Anthem deal, Reuters says
Subscribe for More Information
07:25 EDTBSX, UNH, MDTPiper Jaffray to hold a summit
2015 Piper Jaffray Heartland Summit is being held in Minneapolis on June 23-24.
06:00 EDTHUMHumana implied volatility of 48 at upper end of index
June 22, 2015
18:56 EDTHUM, AET, CICigna/Anthem deal could leave Humana with Aetna as only suitor, Bloomberg says
Subscribe for More Information
17:04 EDTCIOn The Fly: Top stock stories for Monday
Subscribe for More Information
13:20 EDTCIOn The Fly: Top stock stories at midday
Subscribe for More Information
11:29 EDTCIAnthem says not aware of other bidders when making Cigna bid
Subscribe for More Information
11:18 EDTCIAnthem says would suspend buybacks for year with signing of Cigna deal
Anthem (ANTM) says team has worked for months evaluating "realistic" synergies of potential Cigna (CI) deal. Says $2B in synergies within two years post-close "achievable." Sees international opportunities with Cigna acquisition. Says confident on attaining financing for Cigna purchase. Says expects to suspend buybacks for the year with signing of Cigna deal, but sees maintaining dividend. Anthem does not see regulatory issues thwarting deal. Says Cigna acquisition is a strategic priority. Comments being made on Anthem's update reaffirming its commitment to its $184 per share proposal for Cigna.
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use